Comparison between short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease

Chronic GVHD clinical trials often use early endpoints, such as clinical response at 3 or 6 months as the primary endpoint, instead of measures of long-term treatment success, such as the ability to discontinue immunosuppressive treatment after development of immune tolerance and resolution of activ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Martin, Paul J., Storer, Barry E., Carpenter, Paul A., Couriel, Daniel R., Flowers, Mary E.D., Gupta, Vikas, Hsu, Jack W., Jagasia, Madan, Kitko, Carrie L., Maziarz, Richard T., Rowley, Scott D., Shaughnessy, Paul J., van Besien, Koen, Weisdorf, Daniel, Lee, Stephanie J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2974028/
https://ncbi.nlm.nih.gov/pubmed/20601033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2010.06.018
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados